adenine has been researched along with Hormone-Dependent Neoplasms in 3 studies
Excerpt | Relevance | Reference |
---|---|---|
"Amonafide was given at a dose of 225 mg/m2 intravenously daily for 5 days." | 2.67 | Phase II trial of amonafide for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group study. ( Ahmann, F; Blumenstein, B; Craig, JB; Crawford, ED; Eisenberger, M; Marshall, ME; Thompson, IM, 1994) |
"The androgen dependent prostate cancer cell line, LNCaP, expresses the ErbB-1, ErbB-2 and ErbB-3 receptor tyrosine kinases." | 1.38 | Neuregulin promotes incomplete autophagy of prostate cancer cells that is independent of mTOR pathway inhibition. ( Ehrlich, M; Pinkas-Kramarski, R; Schmukler, E; Shai, B, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schmukler, E | 1 |
Shai, B | 1 |
Ehrlich, M | 1 |
Pinkas-Kramarski, R | 1 |
Amaral, C | 1 |
Varela, C | 1 |
Azevedo, M | 1 |
da Silva, ET | 1 |
Roleira, FM | 1 |
Chen, S | 1 |
Correia-da-Silva, G | 1 |
Teixeira, N | 1 |
Marshall, ME | 1 |
Blumenstein, B | 1 |
Crawford, ED | 1 |
Thompson, IM | 1 |
Craig, JB | 1 |
Eisenberger, M | 1 |
Ahmann, F | 1 |
1 trial available for adenine and Hormone-Dependent Neoplasms
Article | Year |
---|---|
Phase II trial of amonafide for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group study.
Topics: Adenine; Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Drug Administration Schedul | 1994 |
2 other studies available for adenine and Hormone-Dependent Neoplasms
Article | Year |
---|---|
Neuregulin promotes incomplete autophagy of prostate cancer cells that is independent of mTOR pathway inhibition.
Topics: Acetylcysteine; Adenine; Anthracenes; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Death | 2012 |
Effects of steroidal aromatase inhibitors on sensitive and resistant breast cancer cells: aromatase inhibition and autophagy.
Topics: Adenine; Androstanes; Aromatase Inhibitors; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Surv | 2013 |